#USA #Boston #TransPerfect #ArisGlobal #NavaX

ArisGlobal's Innovative Step in Pharmacovigilance

In the dynamic world of life sciences, accurate and timely handling of safety reports is critical. ArisGlobal, a pioneer in AI-driven technologies, has unveiled its latest offering—NavaX Translation. This groundbreaking solution aims to revolutionize how pharmaceutical companies manage safety data across multiple languages, effectively eliminating manual translation processes.

Understanding the Challenge

Global pharmacovigilance teams are inundated with safety reports submitted in various languages. Traditionally, this workload necessitated manual operations that involved exporting data, coordinating with third-party vendors, and reintegrating translated content into safety systems. Such an approach is not only time-consuming but also fraught with potential errors, thereby jeopardizing regulatory compliance.

Introducing NavaX Translation

NavaX Translation is set to change this narrative. Delivered through a strategic collaboration with TransPerfect Life Sciences, the solution incorporates certified, pharma-grade translations directly into the LifeSphere Safety workflows. This enables a more agile, compliant, and efficient response to safety reporting on a global scale.

During a recent announcement, Jason Bryant, Senior Vice President of AI Data Product Management at ArisGlobal, emphasized the significance of this development, stating, “NavaX Translation reflects our commitment to embedding intelligent automation directly into core workflows.”

How It Works

NavaX Translation employs intelligent language detection, automatically identifying non-English safety reports. These reports are then routed for translation utilizing AI models specific to the pharmaceutical industry along with insights from expert human linguists at TransPerfect. The translated documents seamlessly integrate back into LifeSphere Safety through an API, drastically reducing the time spent on translation management—from hours to mere minutes.

Key Features:

• - Automatic Multilingual Intake: Instantaneous language detection ensures that reports are processed without delays.
• - Certified Translations: Translations adhere to pharma-grade standards and utilize life sciences-specific models to maintain accuracy.
• - Seamless API Integration: The connection to LifeSphere Safety eliminates the need for manual exports or imports, streamlining operations.
• - Regulatory Compliance: Outputs are crafted to support global regulatory requirements, ensuring that organizations remain compliant.
• - Scalability: Designed to handle high volumes of reports from various markets.

Momentum and Future Projections

The NavaX Translation service builds upon the already robust performance of the NavaX platform, which is currently processing over 1 million safety cases with projections to reach 2.5 million by mid-2026. Notably, performance metrics indicate an impressive data accuracy rate exceeding 95% and operational efficiency improvements greater than 30%. Many organizations are already witnessing a significant return on investment, making this technology a strategic asset.

Kevin Obarski, Chief Growth Officer at TransPerfect, remarked on the partnership's impact, explaining, “By partnering with ArisGlobal, we’re embedding validated translation into a truly intelligent safety platform—enabling life sciences organizations to scale globally with confidence, speed, and regulatory assurance.”

Availability

Starting July 2026, the NavaX Translation solution will be accessible to customers using LifeSphere Safety, paving the way for enhanced operational excellence and adherence to safety standards in the pharmaceutical industry.

For more information about how NavaX Translation can transform your global pharmacovigilance efforts, visit the ArisGlobal website.

With its innovative approach to automating translation and compliance processes, ArisGlobal continues to position itself at the forefront of the life sciences sector, proving that intelligent technology can significantly enhance efficiency and accuracy in safety reporting.

About ArisGlobal

Headquartered in the United States, ArisGlobal is dedicated to changing the landscape of life sciences by providing advanced technologies that facilitate breakthrough developments and efficient market launches. The company holds a prominent place in the industry, with regional offices in Europe, India, Japan, and China. For the latest updates, follow ArisGlobal on LinkedIn.

About TransPerfect Life Sciences

Specializing in comprehensive solutions for the global development and commercialization of drugs and treatments, TransPerfect Life Sciences is a trusted partner for organizations aiming to make a significant impact worldwide. Their services span across a range of functions, including pharmacovigilance, clinical technologies, and language services—all designed to support life-saving innovations.